SUMON MUKHERJEE

About

Immunology researcher with expertise in tumor immunology, immune regulation, and immune evasion mechanisms. My research dissects how regulatory lymphocyte populations subvert anti-tumor immunity, with the goal of translating mechanistic insights into improved cancer immunotherapies.

Employment

• Bose Institute Researcher

Education

• University of Calcutta Ph.D. in Biochemistry
  2018 - 2025
• University of Calcutta Master of Science in Zoology
  2015 - 2017
• University of Burdwan Bachelor of Science in Zoology
  2012 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy
  Apoptosis 2026 DOI: 10.1007/s10495-026-02409-9
  +Save
• Breast cancer stem cells convert anti-tumor CD4+ T cells to pro-tumor T regulatory cells: Potential role of exosomal FOXP3.
  Cellular Immunology 2025 DOI: https://doi.org/10.1016/j.cellimm.2025.104931
  +Save
• hsa-miR-5688 inhibits FOXC1-OCT4/SOX2 feedforward loop that drives chemoresistance in breast cancer stem cells.
  Molecular Therapy. Oncology 2025 DOI: https://doi.org/10.1016/j.omton.2025.200982
  +Save
• Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis.
  Frontiers in Immunology 2025 DOI: https://doi.org/10.3389/fimmu.2025.1655176
  +Save
• The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting.
  Cancer Control 2025 DOI: https://doi.org/10.1177/10732748251406677
  +Save
• In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma.
  Scientific Reports 2025 DOI: org/10.1038/s41598-025-93924-3
  +Save
• FOXP3 Transcriptionally Activates Fatty Acid Scavenger Receptor CD36 in Tumour-Induced Treg Cells.
  Immunology 2025 DOI: https://doi.org/10.1111/imm.13887
  +Save
• Down-regulation and reduced surface-presentation of neoantigens in cancer stem cells decide the fate of cancer immunotherapy: An in-silico mechanistic hypothesis.
  In Silico Research in Biomedicine 2025 DOI: https://doi.org/10.1016/j.insi.2025.100071
  +Save
• Cancer Stem Cells Decide the Fate of Cancer Immunotherapy by Remodeling Tumor Microenvironment.
  Cancer Control 2025 DOI: https://doi.org/10.1177/10732748251381441
  +Save
• Nuclear factor kappa-B: The El Dorado of inflammatory immune response.
  Journal of Cellular and Molecular Immunology 2024 DOI: https://doi.org/10.46439/immunol.3.025
  +Save